학술논문

Survival advantage of treosulfan plus fludarabine (FT14) compared to busulfan plus fludarabine (FB4) in active acute myeloid leukemia post allogeneic transplantation: an analysis from the European Society for Blood and Marrow Transplantation (EBMT) Acute Leukemia Working Party (ALWP)
Document Type
Article
Source
In: Bone Marrow Transplantation. (Bone Marrow Transplantation, October 2023, 58(10):1084-1088)
Subject
Language
English
ISSN
14765365
02683369